Ive Effect Of N-acetylcystiene Against Titaniu...

Peptidomimetics As A New Generation Of Antimicr...

Prevalence Of Autoantibodies Reveals A Predomin...

Dichotomy In Fcγriib Deficiency And Autoimmune...

Production And Characterization Of Monoclonal A...

0 votes
Salivary Carbonic Anhydrase Vi, Zinc Sulfate Taste Acuity And Frequency Of Illness: A Pilot Study
Author: Matthew J. Zdilla And Leah D. Starkey
Publisher: Derivative Works
7 pages
One time payment: €0.00
Required subscription: Free
Type of publication: Article
ISBN/ISSN: 1553-619X
DOI: :10.3844/2014.107.113
Follow this publisher

Share this publication:


Salivary Carbonic Anhydrase VI (CA6) is a zinc-dependent metalloenzyme which may be important for normal taste function. Though many taste assessment methods exist, the assessment of zinc sulfate taste acuity is a method that has been suggested to have diverse relationships to human health. A double-blinded pilot study was conducted among 21 individuals to analyze the relationships between salivary CA6 concentrations, zinc sulfate taste acuity and self-reported frequency of illness. ELISA was performed to quantify CA6 concentrations, the Bryce-Smith and Simpson “Zinc Taste Test” (BS-ZTT) protocol and a Taste Intensity Visual Analog Scale (TI-VAS) were utilized to assess zinc sulfate taste acuity and a health history questionnaire was used to determine the frequency of illness. A statistically significant correlation existed between CA6 concentration and zinc sulfate taste acuity determined via the BS-ZTT (rs = 0.62; p = 0.03). A moderate statistically significant negative correlation was found between self-reported frequency of illness and BS-ZTT scores (rs = -0.64, p = 0.034). Likewise, a strong statistically significant negative correlation was found between self-reported frequency of illness and TI-VAS scores (rs = -0.81, p = 0.003). The results of this pilot study suggest that zinc sulfate taste acuity may be reflective of salivary CA6 concentration in addition to being a retrospective indicator of illness frequency.

About the publisher:

We are a publishing house devoted to reuse CC-BY licensed published materials.


Using CC-BY licenses:


  • Adapt — remix, transform, and build upon the material
  • for any purpose, even commercially.
  • The licensor cannot revoke these freedoms as long as you follow the license terms.


  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others
    from doing anything the license permits.


  • You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
  • No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.

Select a payment method